Free delivery on orders over £200 Order by 4pm - same day dispatch Cold-chain guaranteed delivery Full batch traceability on every order Free delivery on orders over £200 Order by 4pm - same day dispatch Cold-chain guaranteed delivery Full batch traceability on every order

What are Exosomes?

Aesthetics Wise - What are Exosomes

Exosomes are becoming an increasingly popular topic within the aesthetics industry, with growing interest in their potential applications in skin rejuvenation, hair restoration and regenerative aesthetics. As practitioners continue to explore new ways to improve skin quality and address the visible signs of ageing, exosomes are emerging as an area of particular interest.

Unlike traditional aesthetic treatments, such as dermal fillers and hyaluronic acid skin boosters, exosomes are associated with the biological processes that allow cells to communicate with one another. Researchers are investigating how these processes could support the skin’s natural repair and renewal mechanisms.

But what exactly are exosomes, how do they work, and what should UK aesthetic practitioners know before introducing exosome-based products into their clinics?

Let’s explore the science behind exosomes, their potential benefits, how they compare with other aesthetic treatments and the important safety and regulatory considerations surrounding their use.

What Are Exosomes?

Exosomes are microscopic, membrane-enclosed particles released by cells. They belong to a wider group of biological particles known as extracellular vesicles (EVs) and are involved in communication between cells throughout the body.

Typically measuring between 30 and 150 nanometres in diameter, exosomes are considerably smaller than human cells. They can carry a variety of biological materials, including:

  • Proteins
  • Lipids
  • Growth factors
  • Messenger RNA (mRNA)
  • MicroRNA (miRNA)
  • Other biological signalling molecules

These materials can influence how recipient cells behave, making exosomes an important area of research in regenerative medicine, dermatology and aesthetic science.

One simple way to understand exosomes is to think of them as microscopic delivery packages that help cells exchange information.

However, not all extracellular vesicles are exosomes. The International Society for Extracellular Vesicles (ISEV) recommends that researchers use the broader term “extracellular vesicle” by default, and reserve “exosome” for particles whose endosomal origin (the specific way they are formed inside the cell) has been demonstrated. In practice, many products marketed as containing “exosomes” are more accurately described as containing extracellular vesicles.

How Do Exosomes Work?

Exosomes work as part of the body’s complex cellular communication network. When released by a cell, they can interact with other cells and transfer biological signals that influence various cellular processes.

Within aesthetic medicine, researchers are particularly interested in how extracellular vesicles interact with fibroblasts and other skin cells. Fibroblasts are responsible for producing collagen, elastin and other components that contribute to the structure and resilience of the skin.

Laboratory and early clinical research into exosomes has explored their potential to:

  • Influence collagen and elastin production.
  • Support cellular repair and regeneration.
  • Modulate inflammatory responses.
  • Support skin barrier function.
  • Influence tissue remodelling.
  • Help regulate processes associated with skin ageing.

It is these potential properties that have generated significant interest among aesthetic practitioners.

However, demonstrating a biological effect in a laboratory is not the same as proving that a commercially available aesthetic product will deliver meaningful results for clients.

Where Do Exosomes Come From?

Exosomes and other extracellular vesicles can originate from different biological sources. The source of these particles is particularly important because it can influence their composition, safety, biological activity and regulatory classification.

Human-Derived Exosomes

Human-derived exosomes may be obtained from cultured human cells, including mesenchymal stromal cells associated with tissues such as adipose tissue, bone marrow and umbilical cord tissue.

These exosomes are being investigated within regenerative medicine and other areas of medical research.

However, human-derived exosomes are prohibited as ingredients in cosmetic products sold in the UK. Their use in medical research does not mean they are permitted for routine cosmetic treatments.

Plant-Derived Extracellular Vesicles

Plant-derived extracellular vesicles are another area of growing interest within the skincare and aesthetics industries.

These particles may be obtained from various botanical sources, including:

  • Green tea
  • Ginseng
  • Rose
  • Aloe vera
  • Fruit and other botanical extracts

Products containing plant-derived vesicles are often marketed for their potential antioxidant, soothing and skin-conditioning properties. However, their effectiveness depends on the specific formulation and the evidence supporting it.

Plant-derived ingredients are not automatically safe, compliant or suitable for invasive aesthetic procedures.

Animal-Derived Extracellular Vesicles

Extracellular vesicles can also be obtained from animal sources, including milk. These are being investigated for various applications in skincare, biotechnology and medicine.

As with other biological ingredients, manufacturers must consider sourcing, purity, contamination risks, allergens and product safety.

Synthetic Exosome-Inspired Products

Some manufacturers are developing engineered nanoparticles and synthetic vesicles designed to imitate certain characteristics of naturally occurring extracellular vesicles.

Although these products may be described using exosome-related terminology, they are not necessarily genuine biological exosomes. Phrases such as “exosome-derived”, “exosome technology” or “exosome-inspired” can describe very different things. Practitioners should always establish exactly what a product contains rather than relying solely on its marketing description.

What Are Exosomes Used for in Aesthetics?

Exosome-based products are being researched across several areas of aesthetic medicine, particularly where improving overall skin quality is the primary objective.

Skin Rejuvenation and Anti-Ageing

One of the most widely discussed potential applications of exosomes is skin rejuvenation.

As we age, collagen and elastin production changes, cellular renewal slows and the skin gradually loses some of its firmness and elasticity.

Researchers are investigating whether extracellular vesicles could help improve the appearance of:

  • Fine lines and wrinkles
  • Dull and tired-looking skin
  • Uneven skin tone
  • Loss of elasticity
  • Rough skin texture
  • Visible signs of environmental damage

Although early findings are encouraging, further research is needed to establish the effectiveness and long-term safety of individual formulations.

Skin Recovery Following Aesthetic Treatments

Exosomes are also being investigated for their potential role in skin recovery following procedures such as microneedling, laser resurfacing and chemical peels.

The interest in this area stems from the possible influence of extracellular vesicles on inflammatory responses and tissue repair.

However, practitioners must be particularly careful when considering products for use on compromised skin. A cosmetic serum intended for application to intact skin should not automatically be considered suitable for use during or immediately after microneedling. The same caution applies to anything applied to the skin in the hours after a procedure, as covered in our guide to wearing makeup after treatment.

Hair Restoration and Scalp Health

Another emerging area of exosome research is hair restoration.

Scientists are investigating how extracellular vesicles may interact with hair follicles, influence the hair growth cycle and affect the cellular processes associated with hair loss.

While some early studies have reported promising findings, exosome products should not be presented as a proven cure for alopecia or a guaranteed solution for hair regrowth. Practitioners working on scalp quality may already be familiar with polynucleotide-based scalp products such as Plinest Hair and Nucleofill Hair, which have a different composition and regulatory route.

Acne Scarring and Hyperpigmentation

Exosomes are also being studied for their potential influence on tissue remodelling, pigmentation and inflammatory processes.

These areas of research could eventually have implications for the management of acne scarring, uneven pigmentation and other skin concerns. At present, however, the evidence remains insufficient to establish exosome-based products as a reliable alternative to established treatments for these conditions.

What Are the Potential Benefits of Exosomes?

The growing interest in exosomes reflects a broader shift within aesthetics towards treatments that focus on skin quality rather than simply restoring volume or changing facial contours.

Potential benefits currently being investigated include:

  • Improved skin texture: supporting processes associated with smoother-looking skin.
  • Skin firmness and elasticity: influencing cellular activity associated with collagen and elastin.
  • Skin hydration: supporting processes associated with maintaining skin moisture and barrier function.
  • Skin recovery: potentially influencing inflammatory responses and natural repair mechanisms.
  • Improved skin tone: influencing biological pathways associated with pigmentation.
  • Hair and scalp health: potentially influencing hair follicle activity.

These are areas of ongoing research, rather than guaranteed benefits of every product marketed as containing exosomes.

What Does the Research Say About Exosomes?

Although exosomes are frequently described as a breakthrough in regenerative aesthetics, the clinical evidence is still developing.

A systematic review published in Facial Plastic Surgery and Aesthetic Medicine in July 2026 examined 16 studies involving 503 participants who received extracellular vesicle-based interventions for non-surgical facial rejuvenation.

Many of the studies reported improvements in areas such as skin hydration, elasticity, pigmentation and the appearance of wrinkles, and no serious adverse events were reported. However, the researchers judged the risk of bias to be moderate to critical for most effectiveness outcomes and rated the certainty of the available evidence as low or very low.

Several challenges remain within exosome research, including:

  • Relatively small clinical trials.
  • Limited long-term safety data.
  • Differences in manufacturing and purification methods.
  • Inconsistent product concentrations and compositions.
  • A lack of standardised treatment protocols.
  • Limited comparisons with established aesthetic treatments.

Practitioners should therefore assess the evidence supporting the specific product they intend to purchase, rather than assuming that research into one type of extracellular vesicle applies to all exosome-based formulations.

Exosomes vs Polynucleotides vs Skin Boosters

With the increasing popularity of regenerative aesthetics, it is easy to confuse exosomes with polynucleotides, skin boosters and other skin rejuvenation products.

Although these products may share similar aesthetic objectives, they differ considerably in their composition and mechanisms of action.

TreatmentPrimary ComponentMain Purpose or Area of Research
ExosomesCell-derived extracellular vesiclesCellular communication and regenerative processes
PolynucleotidesPurified nucleotide chainsSkin quality, hydration and tissue remodelling
Skin boostersTypically hyaluronic acidSkin hydration, texture and elasticity
Dermal fillersTypically cross-linked hyaluronic acidVolume restoration, contouring and facial definition
BiostimulatorsIngredients such as PLLA or CaHAStimulation of collagen production
Platelet-rich plasma (PRP)Platelet-rich plasma obtained from the clientGrowth factor-mediated tissue repair processes

Each product category has different indications, risks, regulatory requirements and levels of supporting clinical evidence. For more on how hyaluronic acid products differ from one another, see our guide to cross-linked vs non-cross-linked hyaluronic acid.

Exosomes vs Polynucleotides

Polynucleotides are purified chains of nucleotides, commonly sourced from salmon or trout DNA, that are used in aesthetic products designed to improve skin quality. Ranges such as Plinest and Nucleofill are well-known examples.

Exosomes, by comparison, are biological vesicles capable of carrying multiple types of signalling molecules.

While both are associated with regenerative aesthetics, they are not interchangeable, and there is currently insufficient comparative evidence to establish that exosomes are superior to polynucleotides. Our article on skin boosters vs polynucleotides explains how polynucleotides compare with hyaluronic acid products.

Exosomes vs Hyaluronic Acid Skin Boosters

Hyaluronic acid skin boosters primarily focus on improving skin hydration and overall skin quality. Hyaluronic acid has a natural ability to attract and retain water, making it a popular ingredient in aesthetic treatments.

Exosome research focuses more closely on cellular communication and the biological pathways associated with repair and regeneration. If you are weighing up skin boosters, our article debunking skin booster myths covers some of the most common misconceptions.

Exosomes vs Dermal Fillers

Dermal fillers are primarily used to restore lost volume, enhance facial features, improve contours and soften the appearance of certain lines and folds. Our guide to dermal fillers for aesthetic practitioners covers this in more detail.

Exosomes are not volumising agents and should not be considered a replacement for dermal fillers where structural enhancement or volume restoration is required.

Are Exosomes Safe?

As with any emerging aesthetic technology, safety should remain a primary consideration when evaluating exosome-based products.

The safety of a formulation depends on several factors, including its biological source, manufacturing standards, purity, intended application and storage conditions.

Potential risks and safety concerns include:

  • Allergic reactions and skin sensitivity.
  • Redness, irritation and inflammation.
  • Microbial contamination.
  • Infection, particularly where the skin barrier has been breached.
  • Unwanted immune responses.
  • Inconsistent biological activity between product batches.
  • Unknown long-term biological effects.

Although early clinical studies have reported encouraging short-term safety findings, this does not establish the safety of every commercially available exosome product.

Practitioners should be particularly cautious of products sourced through unverified suppliers, products with unclear ingredient information and formulations marketed for uses outside their intended purpose.

Are Exosomes Legal in the UK?

One of the most important considerations for UK aesthetic practitioners is understanding the regulatory position surrounding exosomes.

As of November 2026, the legality of an exosome-based product depends on its ingredients, intended purpose, method of administration, marketing claims and regulatory classification.

Human-Derived Exosomes and UK Cosmetics Regulations

Under Regulation (EC) No 1223/2009 on cosmetic products, as it applies in the UK, cells, tissues and products of human origin are prohibited as cosmetic ingredients.

This restriction is specifically listed under entry 416 of Annex II of the cosmetics regulation.

Consequently, human-derived exosomes cannot legally be marketed as cosmetic skincare products in the UK. Injecting a human-derived formulation does not offer a route around this either: an injected product is not a cosmetic at all, and would instead fall to be assessed under medicines legislation.

Are Injectable Exosomes Approved in the UK?

No UK marketing authorisation for an injectable exosome product specifically intended for aesthetic use has been identified at the time of writing.

Products intended to exert therapeutic or pharmacological effects may fall under medicines legislation and be regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA assesses borderline products according to their individual characteristics, intended use and claims.

Some injectable skin quality products, including many polynucleotide and hyaluronic acid products, are placed on the market as medical devices rather than medicines. Where a product carries a UKCA or CE mark, that marking only covers the intended purpose, composition and route of administration stated by the manufacturer. Practitioners should ask for the device classification, Declaration of Conformity and instructions for use, and check that any “exosome” ingredient named in the marketing is covered by that documentation.

Practitioners can consult the following official resources:

Important: A product being commercially available, supplied in a sterile-looking vial or marketed to aesthetic professionals does not establish that it is authorised for injection. Practitioners should not inject cosmetic exosome products or offer unapproved injectable exosome treatments as routine aesthetic services.

Are Plant-Derived Exosome Cosmetics Legal?

Cosmetic products containing plant-derived extracellular vesicles may be legally marketed in the UK, provided they meet all applicable cosmetic product safety and regulatory requirements.

For products placed on the Great Britain market, these requirements include:

  • A designated Responsible Person established in the UK.
  • A Cosmetic Product Safety Report (CPSR).
  • A Product Information File (PIF).
  • Appropriate ingredient and product labelling.
  • Compliance with good manufacturing practice.
  • Notification through the UK’s cosmetic product notification service.
  • Appropriate evidence to support product claims.

Cosmetic product notification is not the same as regulatory approval or certification of clinical effectiveness.

Further information is available through the Government’s guidance on making cosmetic products available in Great Britain.

Businesses supplying products in Northern Ireland should also familiarise themselves with the separate Northern Ireland cosmetics regulations.

Changes to UK Aesthetics Regulations in 2026

The regulation of non-surgical cosmetic procedures continues to evolve across the UK.

On 21 October 2026, the Department of Health and Social Care opened a consultation on restricting high-risk cosmetic and wellbeing procedures in England. It runs until 13 January 2027. Under the proposals, a defined list of high-risk procedures could only be carried out by doctors, dentists and independent prescribing nurses, midwives and pharmacists, with age restrictions and enforcement by the Care Quality Commission.

Exosomes are not named in the proposed list. However, it does include procedures using therapeutic products derived from human blood or plasma, such as cosmetic PRP, which shows the direction of travel for biologically derived injectables. This sits alongside the Government’s wider plans to introduce licensing for lower-risk non-surgical treatments.

In Scotland, the Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026 received Royal Assent on 12 May 2026. It will prohibit non-surgical procedures for under-18s and restrict where procedures can take place, although most of its non-surgical procedure provisions are being brought into force in stages and are not yet in effect.

Clinic owners should monitor developments through the following resources:

Proposed regulations should not be confused with legislation already in force. Practitioners must also check the requirements applicable to their location, professional registration and treatment activities. You can follow our coverage of regulatory changes on our hot topics page.

Can Exosomes Be Used With Microneedling?

Microneedling and exosomes are frequently discussed together within the aesthetics industry.

Microneedling creates controlled micro-injuries in the skin, stimulating natural repair processes and temporarily disrupting the skin barrier. Researchers are exploring whether extracellular vesicles could complement these processes.

However, practitioners must distinguish between a topical cosmetic product designed for intact skin and a formulation specifically assessed for use on compromised skin.

Before considering any combination treatment, practitioners should establish:

  • Whether the product is legally supplied for its intended use.
  • Whether the manufacturer supports the proposed application.
  • Whether the product’s safety assessment covers that application.
  • Whether appropriate microbiological quality and sterility requirements are met.
  • Whether suitable clinical evidence supports the combination.
  • Whether their professional indemnity insurance covers the procedure.

Where the regulatory status or safety of the proposed application is unclear, the treatment should not proceed until these issues have been resolved.

What Should Aesthetic Practitioners Look for When Buying Exosome Products?

With more manufacturers entering the exosome skincare market, product selection is becoming increasingly important for aesthetic clinics.

Before purchasing an exosome-based product, consider the following.

1. Product Origin and Composition

Establish whether the product contains plant-derived, animal-derived or synthetic vesicles, and get written confirmation that it contains no material of human origin. Request a clear ingredient list and supporting information explaining what the formulation contains.

2. Regulatory Compliance

Check that the product meets the appropriate UK regulatory requirements and that its classification (cosmetic, medical device or medicine) supports the intended application.

3. Manufacturing Standards

Look for transparent information regarding manufacturing quality, purification methods, microbiological testing and batch consistency.

4. Clinical Evidence

Request research and supporting data relevant to the specific formulation. General studies into exosomes are not a substitute for evidence supporting an individual product.

5. Batch Traceability

Ensure that products can be traced through batch numbers, expiry dates, manufacturer details and supplier records. Buying from an established UK aesthetics wholesaler makes this considerably easier.

6. Storage and Handling Requirements

Some biological formulations may require temperature-controlled storage or have a limited shelf life once opened. Always follow the manufacturer’s validated storage and handling instructions.

7. Professional Insurance

Contact your insurance provider before introducing an unfamiliar treatment. Existing cover for microneedling, dermal fillers or skin boosters does not necessarily extend to exosome-based procedures.

Introducing Exosome Products Into Your Aesthetics Business

For aesthetics business owners, introducing a new product involves considerably more than simply adding another treatment to the price list.

Before investing in an exosome-based product range, clinics should consider:

  • Product purchasing costs and potential profit margins.
  • Practitioner training and competency requirements.
  • Professional indemnity insurance costs.
  • Client consultation and informed consent procedures.
  • Storage, stock management and product wastage.
  • Infection prevention and control, including suitable clinic consumables.
  • Adverse reaction management and reporting procedures.
  • Marketing and advertising compliance.
  • Realistic client expectations.

Short shelf lives and cold-chain requirements also change the economics of stocking up. Our article on whether bulk buying increases profit covers how to weigh unit price against wastage.

For example, a clinic may discover a competitively priced exosome serum marketed for use alongside microneedling. However, if the supplier cannot establish its regulatory status, provide suitable safety documentation or demonstrate that the proposed application is covered, the clinic should not introduce that combination treatment.

Building a successful aesthetics business means balancing commercial opportunities with client safety, professional responsibilities and long-term reputation.

Practitioners should also familiarise themselves with the Office for Product Safety and Standards’ cosmetic adverse effect reporting guidance and the MHRA’s Yellow Card reporting scheme for relevant healthcare products.

Advertising Exosome Treatments in the UK

Exosomes have attracted considerable attention on social media, with some products promoted using dramatic claims about reversing ageing, regenerating skin and restoring hair growth.

However, UK aesthetics businesses must comply with advertising standards established by the Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP).

Practitioners should avoid unsupported claims such as:

  • Reverses the ageing process.
  • Guarantees hair regrowth.
  • Completely regenerates damaged skin.
  • Eliminates wrinkles permanently.
  • Is completely risk-free.
  • Is clinically proven without appropriate supporting evidence.
  • Delivers guaranteed results after one treatment.

In May 2026, the ASA upheld a complaint against an exosome-branded skincare product whose listing claimed a measurable lifting effect based on a small trial. Notably, the ASA found that softer wording such as “helps” and “supports” did not make up for a lack of robust evidence. Qualifying language is not a substitute for substantiation.

Businesses must also ensure that advertising for cosmetic interventions is not targeted at under-18s.

Further information can be found in the CAP Code covering medicines, medical devices, health-related products and beauty products.

Are Exosomes the Future of Regenerative Aesthetics?

The aesthetics industry has seen a noticeable shift towards products that focus on improving skin quality and supporting biological processes rather than simply addressing individual signs of ageing.

The growing interest in polynucleotides, skin boosters, collagen biostimulators and extracellular vesicles reflects this wider trend.

Exosomes represent an exciting area of scientific research, with potential applications extending well beyond aesthetics into dermatology and regenerative medicine.

However, before exosome-based treatments can become an established part of mainstream aesthetic practice, further progress is needed in clinical research, manufacturing standardisation, long-term safety assessments and regulatory compliance.

For practitioners, staying informed about these developments is just as important as keeping up with emerging aesthetic trends.

Frequently Asked Questions About Exosomes

Are exosomes stem cells?

No. Exosomes are microscopic extracellular vesicles released by cells, including stem cells. They are not living cells and cannot reproduce independently or develop into different types of tissue.

Do exosomes stimulate collagen production?

Laboratory research suggests that certain extracellular vesicles can influence fibroblast activity and biological pathways associated with collagen production. However, this does not mean that every commercially available exosome product has a proven collagen-stimulating effect.

Are exosomes better than polynucleotides?

Not necessarily. Exosomes and polynucleotides have different compositions and proposed mechanisms of action. There is currently insufficient direct comparative clinical evidence to determine whether one is consistently more effective than the other.

How long do exosome treatment results last?

There is currently no established, clinically validated duration of results that applies to all exosome products. Any observed improvements may vary depending on the formulation, application method and individual skin characteristics. This differs from hyaluronic acid products, where typical longevity is better documented, as covered in how long dermal fillers actually last.

Can exosomes help with hair loss?

Exosomes are being investigated for their potential influence on hair follicle activity and hair growth. Although preliminary research is promising, they should not be considered a proven or guaranteed treatment for hair loss.

Are human-derived exosomes banned in the UK?

Human-derived exosomes are prohibited as ingredients in cosmetic products sold in the UK. Medical research and medicinal products are governed by separate regulatory frameworks.

Can exosomes replace dermal fillers?

No. Exosomes do not provide the structural support or volumising effects associated with dermal fillers. They are primarily being investigated for their potential influence on cellular communication, skin quality and regenerative processes.

Can exosomes be injected in the UK?

At the time of writing, no UK marketing authorisation for an injectable exosome product specifically for aesthetic use has been identified. Cosmetic formulations should never be injected.

Are exosomes covered by the 2026 high-risk procedures consultation?

Exosomes are not specifically named in the procedures listed in the October 2026 consultation for England. The proposals do cover procedures using products derived from human blood or plasma, and the final list may change once the consultation closes on 13 January 2027.

Final Thoughts

Exosomes are one of the most talked-about developments in regenerative aesthetics, offering an interesting insight into how cellular communication could shape the future of skin rejuvenation, tissue repair and hair restoration.

While emerging research is encouraging, aesthetic practitioners must remain mindful of the limitations of current clinical evidence, the importance of product quality and the regulatory restrictions surrounding certain exosome-based formulations.

As the aesthetics industry continues to evolve, informed product selection, responsible treatment planning and client safety should always remain at the heart of professional practice.

Discover Professional Aesthetic Products With Aesthetics Wise

At Aesthetics Wise, we understand the importance of keeping up with the latest developments in aesthetic medicine while having access to quality products for your clinic.

From dermal fillers and skin boosters to polynucleotides and essential clinic consumables, we supply a wide range of professional aesthetic products to practitioners across the UK.

Whether you are looking to expand your existing treatment portfolio or restock your clinic essentials, we are here to support your aesthetics business. If you have a question about a product’s regulatory status or documentation, contact our team.

Explore our range of professional aesthetic products at Aesthetics Wise today.

This article is intended for educational and informational purposes and does not constitute medical or regulatory advice. Information reflects the available research and UK regulatory position at the time of writing in November 2026. Practitioners should independently verify the regulatory status, intended use and safety of individual products before introducing them into clinical practice.

0
    0
    Your Basket
    Your basket is empty